Zhejiang Conba Pharmaceutical Co., Ltd. Class ASSE: 600572

"Zhejiang CONBA Pharmaceutical Co., Ltd."Announcement on Key Operating Data for the First Half of 2026

Aug 26, 2026 · Issued by Zhejiang Conba Pharmaceutical Co., Ltd. Class A via Shanghai Stock Exchange

Announcement on Key Operating Data for the First Half of 2026

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Earlier from Zhejiang Conba Pharmaceutical Co., Ltd. Class A

"Zhejiang CONBA Pharmaceutical Co., Ltd."Announcement on Progress in Public Listing for Transfer of 100% Equity in Dongyang Kang'enbei Printing and Packaging Co., Ltd.Aug 18
"Zhejiang CONBA Pharmaceutical Co., Ltd."Indicative Announcement on the Restricted Exercise Period under the 2022 Stock Option Incentive PlanAug 5
"Zhejiang CONBA Pharmaceutical Co., Ltd."Announcement on Obtaining Notice of Approval for Drug Clinical Trial for New Indication of Shexiang Tongxin Dropping Pills by SubsidiaryJul 25
"Zhejiang CONBA Pharmaceutical Co., Ltd."Announcement on the Subsidiary's Rivaroxaban Tablets Obtaining Supplementary Approval for Additional Specifications and Other MattersJul 14

All Zhejiang Conba Pharmaceutical Co., Ltd. Class A news releases